Clinical study of apatinib mesylate combined with paclitaxel in second-line and second-line maintenance therapy for advanced gastric cancer - open, single-arm exploratory study
Latest Information Update: 20 Jul 2018
At a glance
- Drugs Paclitaxel (Primary) ; Rivoceranib (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
Most Recent Events
- 20 Jul 2018 New trial record